DHP-Frimal Contraindications


Mersifarma TM
Full Prescribing Info
Hypersensitivity to dihydroartemisinin and piperaquine phosphate. Severe renal damage or liver disease. Blood disorders. Severe malaria according to WHO definition, drugs that prolong the QTc interval, symptomatic cardiac arrhythmias, severe hypertension, left ventricular hypertrophy (including hypertrophic cardiomyopathy) or congestive cardiac failure accompanied by reduced left ventricle ejection fraction, electrolyte disturbances, particularly hypokalaemia, hypocalcaemia or hypomagnesaemia. Pregnancy.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in